<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
AMENDMENT NO. 1 TO
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Allou Health & Beauty Care, Inc.
--------------------------------
(Name of Issuer)
Class A Common Stock, $0.001 par value per share
--------------------------------
(Title of Class of Securities)
019782101
--------------------------------
(CUSIP Number)
RFE Investment Partners VI, L.P.
36 Grove Street
New Canaan, CT 06840
Telephone: (203) 966-2800
Attention: Mr. Howard C. Landis
with a copy to:
Finn Dixon & Herling LLP
One Landmark Square
Stamford, CT 06901
Telephone: (203) 325-5000
Attention: Charles J. Downey III, Esq.
--------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
July 25, 2000
--------------------------------
(Date of Event which Requires Filing of this Statement)
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
RFE Investment Partners VI, L.P.
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
WC
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Delaware
------------------------------------------------------------------------------
Number of (7) Sole Voting Power 1,300,000, upon the exercise
Shares Bene- of the Warrant described
ficially Owned herein
by Each
Reporting (8) Shared Voting Power 0
Person With
(9) Sole Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
(10) Shared Dispositive Power 0
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant described herein
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common upon exercise of Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
PN
Page 2 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
RFE Associates VI, LLC
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Delaware
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 1,3000,000, upon the exercise
Shares Bene- of the Warrant described
ficially Owned herein
by Each
Reporting (8) Shared Voting Power 0
Person With
(9) Sole Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
(10) Shared Dispositive Power
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common Stock upon the exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
OO - LLC
Page 3 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
RFE Management Corporation
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Delaware
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 0
Shares Bene-
ficially Owned (8) Shared Voting Power 1,300,000, upon the exercise
by Each of the Warrant described
Reporting herein
Person With
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common Stock upon the exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IA
Page 4 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
A. Dean Davis
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 0
Shares Bene-
ficially Owned (8) Shared Voting Power 1,300,000, upon the exercise
by Each of the Warrant described
Reporting herein
Person With
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common Stock upon the exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
Page 5 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
Michael J. Foster
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 0
Shares Bene-
ficially Owned (8) Shared Voting Power 1,300,000, upon the exercise
by Each of the Warrant described
Reporting herein
Person With
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common Stock upon the exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
Page 6 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
Howard C. Landis
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 0
Shares Bene-
ficially Owned (8) Shared Voting Power 1,300,000, upon the exercise
by Each of the Warrant described
Reporting herein
Person With
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8%of the Class A Common Stock upon exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
Page 7 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
James A. Parsons
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 0
Shares Bene-
ficially Owned (8) Shared Voting Power 1,300,000, upon the exercise
by Each of the Warrant described
Reporting herein
Person With
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common Stock upon exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
Page 8 of 12
<PAGE>
Cusip No. 019782101 SCHEDULE 13D
1 Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
Andrew J. Wagner
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF
--------------------------------------------------------------------------------
5 Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or
2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
--------------------------------------------------------------------------------
Number of (7) Sole Voting Power 0
Shares Bene-
ficially Owned (8) Shared Voting Power 1,300,000, upon the exercise
by Each of the Warrant described
Reporting herein
Person With
(9) Sole Dispositive Power 0
(10) Shared Dispositive Power 1,300,000, upon the exercise
of the Warrant described
herein
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each
Reporting Person
1,300,000, upon the exercise of the Warrant
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
18.8% of the Class A Common Stock upon exercise of the Warrant
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions)
IN
Page 9 of 12
<PAGE>
AMENDMENT NO. 1 TO STATEMENT ON SCHEDULE 13D
This Amendment No. 1 amends the Statement on Schedule 13D filed by the
reporting persons identified on the signature pages hereto with respect to the
Class A Common Stock, $.001 par value per share (the "Class A Common Stock"), of
Allou Health & Beauty Care, Inc., a Delaware corporation ("Allou").
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERTAKINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
For purposes of clarification, the fourth paragraph of Item 6 of the
initial statement on Schedule 13D is hereby amended and restated in its entirety
to provide as follows:
"Under the terms of the Warrant, if Allou fails to achieve certain
earnings, earnings per share or daily trading volume thresholds, the holders of
a majority of the outstanding Warrants may, at any time from and after July 25,
2005, require Allou to purchase all of the remaining Warrants at a price of
$8.00 per Warrant, as adjusted for splits, reverse splits, stock dividends and
the like."
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit A Agreement among the Reporting Persons regarding filing of Schedule 13D
Page 10 of 12
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated August 10, 2000
RFE Investment Partners VI, L.P.
By: RFE Associates VI, LLC,
its General Partner
By: /s/ MICHAEL J. FOSTER
------------------------------------
Title: Managing Member
RFE Associates VI, LLC
By: /s/ MICHAEL J. FOSTER
------------------------------------
Title: Managing Member
/s/ A. DEAN DAVIS
----------------------------------------
A. Dean Davis
/s/ MICHAEL J. FOSTER
----------------------------------------
Michael J. Foster
/s/ HOWARD C. LANDIS
----------------------------------------
Howard C. Landis
/s/ JAMES A. PARSONS
----------------------------------------
James A. Parsons
/s/ ANDREW J. WAGNER
----------------------------------------
Andrew J. Wagner
RFE Management Corporation
By: /s/ MICHAEL J. FOSTER
------------------------------------
Title: Vice President and Secretary
Page 11 of 12
<PAGE>
EXHIBIT A
Each of the undersigned hereby agrees that the Amendment No. 1 to
Schedule 13D filed on the date hereof with respect to the shares of Class A
Common Stock of Allou Health & Beauty Care, Inc. has been filed on behalf of the
undersigned.
SIGNATURE:
Dated August 10, 2000
RFE Investment Partners VI, L.P.
By: RFE Associates VI, LLC,
its General Partner
By: /s/ MICHAEL J. FOSTER
------------------------------------
Title: Managing Member
RFE Associates VI, LLC
By: /s/ MICHAEL J. FOSTER
------------------------------------
Title: Managing Member
/s/ A. DEAN DAVIS
----------------------------------------
A. Dean Davis
/s/ MICHAEL J. FOSTER
----------------------------------------
Michael J. Foster
/s/ HOWARD C. LANDIS
----------------------------------------
Howard C. Landis
/s/ JAMES A. PARSONS
----------------------------------------
James A. Parsons
/s/ ANDREW J. WAGNER
----------------------------------------
Andrew J. Wagner
RFE Management Corporation
By: /s/ MICHAEL J. FOSTER
------------------------------------
Title: Vice President and Secretary
Page 12 of 12
